LYFE Capital
Elliott Sun is a Senior Associate at LYFE Capital since July 2021, focusing on therapeutic investments from Series A to IPO and late-stage private equity opportunities in CDMO and supply chains across the US and Asia. Prior to this role, Elliott Sun was an Associate at Baidu Venture from April 2020 to July 2021, where involvement included corporate strategy, investment in biotech, and serving as a founding team member of Biomap Inc., an AI biotech spin-off. Additional experience includes an Analyst position at Baidu Venture, participation in the Oxford Saïd Finance Lab, and legal and research roles at DeHeng Law Offices and Hokkaido University, respectively. Elliott Sun holds a PhD in Medical Sciences from the University of Oxford, an MSc with distinction in Cancer from UCL Cancer Institute, and dual undergraduate degrees in Biochemical Engineering and Law from Xiamen University.
This person is not in any offices
LYFE Capital
At LYFE, they share the passion of our entrepreneurs in their objectives of striving for a better world; one step at a time. Not only do we invest in healthcare but we also bring significant deep seated China knowledge and international business experience to accelerate our partners in their growth, expanding a strong stable company more readily to take on the challenges in the China market.